STERIS plc — Director's Dealing 2021

Oct 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2021-10-01

Reporting Person: Madsen Julia (Senior VP, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-01	Ordinary Shares	A	576	$0.00	Acquired	6433	Direct
2021-10-01	Ordinary Shares	D	121	$228.36	Disposed	6312	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-01	Employee Stock Option (right to buy)	$228.36	A	3152	Acquired	2031-10-01	Ordinary Shares (3152)	Direct

Footnotes

F1: All 576 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 3, 2022; 144 on October 2, 2023; 144 on October 1, 2024 and 144 on October 1, 2025.

F2: 3,737 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025.

F3: 121 shares were withheld from the 349 restricted shares that vested on October 1, 2021. These 121 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 349 restricted shares were part of an award of 1,396 ordinary shares that were awarded to Ms. Madsen on October 1, 2020. These vested shares were valued at the NYSE closing market price on October 1, 2021.

F4: This option becomes exercisable as follows: 788 on October 3, 2022; 788 on October 2, 2023; 788 on October 1, 2024 and 788 on October 1, 2025.